Through a detailed analysis of the association between cirrhosis status, liver etiology, gender, age, and tumor size with DNA methylation changes, we identified DNA methylation changes in HOXA1-, CLEC11A-, AK055957-, and TSPYL5-associated clinical risk factors. This evidence concerns the gene CLEC11A and Cirrhosis.